⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
globenewswire.com
AMGN
AZN
DBVT
GSK
B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 - Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030
globenewswire.com
JNJ
AZN
BMY
NVS
GSK
AMGN
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Bispecific Antibodies Market Research and Competitive Landscape Report 2026: Comprehensive Insights Into Over 180 Companies and 250 Drugs
globenewswire.com
JNJ
AMGN
AZN
MAC
Advocacy Marketing Partners Adds Executive Leader
accessnewswire.com
AMGN
JNJ
HPQ
AAPL
LLY
Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight
globenewswire.com
EDSA
VERU
PLTR
HLIO
DRCT
BHVN
CART
AMGN
AROW
AZN
GSK
NVS
SNDX
SNY
UNH
VRTX
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month
globenewswire.com
AMGN
BMY
GSK
JNJ
REGN
SNY
PFE
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars
businesswire.com
BIIB
AMGN
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
prnewswire.com
AMGN
Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035 - United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate
globenewswire.com
UTHR
PFE
AMGN
JNJ
ABBV
MRK
BMY
MAC